Logo image of ALENT.PA

ETHERO (ALENT.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALENT - FR0010424697 - Common Stock

1.5 EUR
+0.06 (+4.17%)
Last: 12/24/2025, 7:00:00 PM
Fundamental Rating

3

Overall ALENT gets a fundamental rating of 3 out of 10. We evaluated ALENT against 20 industry peers in the Interactive Media & Services industry. ALENT has a medium profitability rating, but doesn't score so well on its financial health evaluation. ALENT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ALENT had positive earnings in the past year.
Of the past 5 years ALENT 4 years were profitable.
In multiple years ALENT reported negative operating cash flow during the last 5 years.
ALENT.PA Yearly Net Income VS EBIT VS OCF VS FCFALENT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500K -1M -1.5M

1.2 Ratios

ALENT's Return On Assets of 1.84% is on the low side compared to the rest of the industry. ALENT is outperformed by 60.00% of its industry peers.
With a Return On Invested Capital value of 14.66%, ALENT perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
ALENT had an Average Return On Invested Capital over the past 3 years of 82.53%. This is significantly above the industry average of 19.90%.
The last Return On Invested Capital (14.66%) for ALENT is well below the 3 year average (82.53%), which needs to be investigated, but indicates that ALENT had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.84%
ROE N/A
ROIC 14.66%
ROA(3y)5.37%
ROA(5y)19.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)82.53%
ROIC(5y)N/A
ALENT.PA Yearly ROA, ROE, ROICALENT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

The Profit Margin of ALENT (8.45%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ALENT has grown nicely.
ALENT has a Operating Margin (14.26%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ALENT has declined.
Industry RankSector Rank
OM 14.26%
PM (TTM) 8.45%
GM N/A
OM growth 3Y-5.86%
OM growth 5YN/A
PM growth 3Y-11.77%
PM growth 5Y33.49%
GM growth 3YN/A
GM growth 5YN/A
ALENT.PA Yearly Profit, Operating, Gross MarginsALENT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ALENT is creating value.
Compared to 1 year ago, ALENT has about the same amount of shares outstanding.
The number of shares outstanding for ALENT remains at a similar level compared to 5 years ago.
There is no outstanding debt for ALENT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALENT.PA Yearly Shares OutstandingALENT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALENT.PA Yearly Total Debt VS Total AssetsALENT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

Based on the Altman-Z score of -0.39, we must say that ALENT is in the distress zone and has some risk of bankruptcy.
ALENT has a worse Altman-Z score (-0.39) than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.39
ROIC/WACC1.81
WACC8.08%
ALENT.PA Yearly LT Debt VS Equity VS FCFALENT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M

2.3 Liquidity

A Current Ratio of 1.18 indicates that ALENT should not have too much problems paying its short term obligations.
With a Current ratio value of 1.18, ALENT is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
ALENT has a Quick Ratio of 1.18. This is a normal value and indicates that ALENT is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.18, ALENT perfoms like the industry average, outperforming 45.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
ALENT.PA Yearly Current Assets VS Current LiabilitesALENT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

3

3. Growth

3.1 Past

ALENT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 143.51%, which is quite impressive.
Measured over the past years, ALENT shows a very strong growth in Earnings Per Share. The EPS has been growing by 40.85% on average per year.
The Revenue for ALENT has decreased by -23.68% in the past year. This is quite bad
The Revenue has been growing slightly by 5.57% on average over the past years.
EPS 1Y (TTM)143.51%
EPS 3Y-23.13%
EPS 5Y40.85%
EPS Q2Q%-120.9%
Revenue 1Y (TTM)-23.68%
Revenue growth 3Y-12.89%
Revenue growth 5Y5.57%
Sales Q2Q%-18.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALENT.PA Yearly Revenue VS EstimatesALENT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 150.00, ALENT can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of ALENT indicates a slightly more expensive valuation: ALENT is more expensive than 70.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.57. ALENT is valued rather expensively when compared to this.
Industry RankSector Rank
PE 150
Fwd PE N/A
ALENT.PA Price Earnings VS Forward Price EarningsALENT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALENT is valued a bit more expensive than 65.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 37.54
ALENT.PA Per share dataALENT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)3.67
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALENT!.
Industry RankSector Rank
Dividend Yield 0%

ETHERO

EPA:ALENT (12/24/2025, 7:00:00 PM)

1.5

+0.06 (+4.17%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.76M
Revenue(TTM)558.40K
Net Income(TTM)47.20K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 150
Fwd PE N/A
P/S 10.32
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 37.54
EPS(TTM)0.01
EY0.67%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.15
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)3.67
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.84%
ROE N/A
ROCE 19.94%
ROIC 14.66%
ROICexc N/A
ROICexgc N/A
OM 14.26%
PM (TTM) 8.45%
GM N/A
FCFM N/A
ROA(3y)5.37%
ROA(5y)19.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)82.53%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)112.29%
ROCE(5y)166.87%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-5.86%
OM growth 5YN/A
PM growth 3Y-11.77%
PM growth 5Y33.49%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z -0.39
F-ScoreN/A
WACC8.08%
ROIC/WACC1.81
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)143.51%
EPS 3Y-23.13%
EPS 5Y40.85%
EPS Q2Q%-120.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.68%
Revenue growth 3Y-12.89%
Revenue growth 5Y5.57%
Sales Q2Q%-18.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-58.54%
EBIT growth 3Y-18%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y110.31%
FCF growth 3Y-17.99%
FCF growth 5YN/A
OCF growth 1Y111.62%
OCF growth 3Y-17.82%
OCF growth 5YN/A

ETHERO / ALENT.PA FAQ

What is the fundamental rating for ALENT stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALENT.PA.


What is the valuation status for ALENT stock?

ChartMill assigns a valuation rating of 0 / 10 to ETHERO (ALENT.PA). This can be considered as Overvalued.


Can you provide the profitability details for ETHERO?

ETHERO (ALENT.PA) has a profitability rating of 4 / 10.


What is the valuation of ETHERO based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ETHERO (ALENT.PA) is 150 and the Price/Book (PB) ratio is -162.25.


Can you provide the financial health for ALENT stock?

The financial health rating of ETHERO (ALENT.PA) is 3 / 10.